Actively Recruiting
Medical Decision Making in Multiple System Atrophy
Led by Medical University Innsbruck · Updated on 2025-02-05
92
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical study is to evaluate the effects of a personalized symptomatic treatment plan integrated with monthly telemedicine and mobile palliative care interventions on a population of individuals diagnosed with Multiple System Atrophy (MSA) and their informal caregivers. The aim is to improve the quality of life of MSA patients and their caregivers, as well as provide them with better support during the disease progression. After a baseline visit, all 46 patients will receive a personalized therapeutic plan (including medical treatment, physiotherapy, logotherapy and occupational therapy excercises and psychological support) and contact with social workers and a palliative care team. They willl then be re-evaluated at 6-,12-, 18- month visits. Semi-structured online interviews at baseline and 12 month visit will collect patients' individual healthcare preferences, which will be taken into account in the preparation of the individual therapeutic plan. Twenty-three patients will be randomized to receive monthly telemedicine visits. Assessment of patients´satisfaction with the therapeutic plan, with the palliative interventions (when they occurred) and the telemedicine visits will be carried over the 18 month period. Forty-six informal caregivers will be invited to participate with semi-structured online interviews and assessment of their QoL and caregivers' burden.
CONDITIONS
Official Title
Medical Decision Making in Multiple System Atrophy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 30 years or older at the time of consent
- Diagnosed with clinically probable or clinically established Multiple System Atrophy
- Life expectancy of at least 24 months as assessed by the investigator
- Understands and agrees to comply with study procedures and provides written informed consent personally
- Signed and dated informed consent document
- Fluency in German
- If unable to walk or stand without assistance at consent, lives in Tyrol or another Austrian region with mobile palliative care available
- Informal caregiver of an individual with MSA recruited in this study
- Informal caregivers aged 18 years or older
- Caregivers understand and agree to provide information and participate in online interviews
- Caregivers provide signed and dated written informed consent
- Caregivers have full legal capacity
- Caregivers are fluent in German
You will not qualify if you...
- Participation in an interventional clinical study that interferes with the personalized treatment plan or telemedicine and mobile palliative care
- Charlson comorbidity index greater than 4 at the time of consent
- Other major medical conditions that may affect study results as assessed by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Innsbruck Medical University
Innsbruck, Austria, Austria, 6020
Actively Recruiting
Research Team
A
Alessandra Fanciulli, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here